We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.
- Authors
Butrous, Ghazwan
- Abstract
Phosphodiesterase inhibitors (PDE) can be used as therapeutic agents for various diseases such as dementia, depression, schizophrenia and erectile dysfunction in men, as well as congestive heart failure, chronic obstructive pulmonary disease, rheumatoid arthritis, other inflammatory diseases, diabetes and various other conditions. In this review we will concentrate on one type of PDE, mainly PDE5 and its role in pulmonary vascular diseases.
- Subjects
PHOSPHODIESTERASE inhibitors; PULMONARY circulation disorders; DRUG efficacy; PERIPHERAL vascular disease treatment; RHEUMATOID arthritis treatment; HEART failure treatment
- Publication
Global Cardiology Science & Practice, 2014, Vol 2014, Issue 4, p60
- ISSN
2305-7823
- Publication type
Article
- DOI
10.5339/gcsp.2014.42